Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: airtight package for oversea shipment
Transportation: Ocean,Land,Air,Express
Supply Ability: in stock
Port: BEIJING,SHANGHAI,QINGDAO
Payment Type: T/T,L/C,Paypal,D/P,D/A
Incoterm: FOB,CIF
Bilastine is an oral non-sedative histamine H1 receptor antagonist developed by Spain's FAES pharmaceutical company. It was approved by the European Union in August 2012 for the treatment of allergic rhinitis and urticaria. Phase clinical study. This product selectively acts on peripheral histamine receptors, has no effect on other histamine receptors, has no cardiotoxicity, is rapidly absorbed after oral administration, has good tolerance, safety and high bioavailability.
Product Categories : API Intermediates > Bilastine Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.